Future research should prioritize elucidating the specific mechanisms through which GLRX3 contributes to tumor progression and developing targeted therapeutic strategies to enhance prognosis and treatment outcomes for liver cancer patients (51). This evidence concerns the gene GLRX3 and liver cancer.